Free shipping on all orders over $ 500

BRD4/CK2-IN-1

Cat. No. M45293

All AbMole products are for research use only, cannot be used for human consumption.

BRD4/CK2-IN-1  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

BRD4/CK2-IN-1 is a potent, orally active dual-targeted inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2) with IC50 values of 180 nM and 230 nM, respectively.BRD4/CK2-IN-1 exhibits potent anticancer activity without significant toxicity and induces apoptosis and autophagy-related cell death in triple-negative breast cancer (TNBC). autophagy-related cell death in triple negative breast cancer (TNBC).

Chemical Information
Molecular Weight 564.03
Formula C29H30ClN5O5
CAS Number 2756851-99-5
Form Solid
Solubility (25°C) DMSO 20 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Xuesong Li, et al. Acta Pharm Sin B. Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB-P300-BRD4 axis

[2] Beibei Liu, et al. Proc Natl Acad Sci U S A. BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer

[3] Jian Wang, et al. Clin Transl Med. BRD4-IRF1 axis regulates chemoradiotherapy-induced PD-L1 expression and immune evasion in non-small cell lung cancer

[4] Shwu-Yuan Wu, et al. Mol Cell. Opposing Functions of BRD4 Isoforms in Breast Cancer

[5] Benedetta Donati, et al. Mol Cancer. BRD4 and Cancer: going beyond transcriptional regulation

Related Casein Kinase Products
SJ3149 

SJ3149 is a selective and potent degrader of CK1α protein in vitro and in vivo.

CK1α degrader-1 

CK1α degrader-1 is an orally active CK1α degrader with a DC50 of 0.105 μM.

ON 108600

ON 108600 is an inhibitor of CK2 (Casein Kinase2)/TNIK/DYRK1 with IC50 values of 0.016 μm/0.007 μM, 0.028 μM, 0.05 μM/0.005 μM, and 0.005 μM for DYRK1A/DYRKB, DYRK2, CK2α1/CK2α2, and TNIK, respectively. 0.005 μM. It has anti-tumor activity.

(R)-DRF053 dihydrochloride

(R)-DRF053 dihydrochloride is a potent inhibitor of casein kinase 1 (CK1), CDK1/cyclin B, and CDK5/p25, with IC50s of 14 nM, 220 nM, and 80 nM, respectively.(R)-DRF053 dihydrochloride prevented the production of CK1-dependent amyloid-β in cellular models. In addition, (R)-DRF053 dihydrochloride prevented the production of CK1-dependent amyloid-β in cell models.

Casein kinase 1δ-IN-5

Casein kinase 1δ-IN-5 is a potent and selective protein kinase CK-1δ inhibitor with an IC50 of 47 nM, which has neuroprotective and anti-inflammatory properties in vitro. It has neuroprotective and anti-inflammatory properties in vitro. It can be used in studies related to neurodegenerative diseases.

  Catalog
Abmole Inhibitor Catalog




Keywords: BRD4/CK2-IN-1 supplier, Casein Kinase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.